DHI
41
9
PFE
41
12
DVA
47
-3
FOX
64
2
OI
58
-2
RSG
45
-3
GE
72
4
HRB
42
-2
WDC
66
2
FTI
58
-5
GME
72
-3
MPC
36
-3
KLAC
70
5
AME
66
4
CF
44
-4
NWL
58
-3
AVY
54
-7
DHR
64
2
PSX
35
-4
TSCO
50
-3
DHI
41
9
PFE
41
12
DVA
47
-3
FOX
64
2
OI
58
-2
RSG
45
-3
GE
72
4
HRB
42
-2
WDC
66
2
FTI
58
-5
GME
72
-3
MPC
36
-3
KLAC
70
5
AME
66
4
CF
44
-4
NWL
58
-3
AVY
54
-7
DHR
64
2
PSX
35
-4
TSCO
50
-3
Financhill
Back

WisdomTree EM ex-State-Owned Enterprises Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
66

XSOE
WisdomTree EM ex-State-Owned Enterprises

Last Price:
$38.65
Seasonality Move:
1.24%
Sell
27

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
66
WisdomTree EM ex-State-Owned Enterprises (XSOE) is a Buy

Is WisdomTree EM ex-State-Owned Enterprises a Buy, Sell or Hold?

  • The current WisdomTree EM ex-State-Owned Enterprises [XSOE] share price is $38.21. The Score for XSOE is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • XSOE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.53. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XSOE Stock Price Chart

What is WisdomTree EM ex-State-Owned Enterprises's stock price today?

  • The WisdomTree EM ex-State-Owned Enterprises share price today is $38.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XSOE is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

XSOE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.38 Buy
Relative Strength Index (14 RSI): 46.6 Sell
Chaikin Money Flow: -62071 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 44.15 Sell
Chaikin Money Flow: -6795 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

XSOE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.4 Sell
20-day SMA: 38.29 Sell
50-day SMA: 38.58 Sell
200-day SMA: 34.98 Buy
8-day EMA: 15.02 Buy
20-day EMA: 6.89 Buy
50-day EMA: 2.92 Buy
200-day EMA: 0.75 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.26 Sell
20-day SMA: 11.59 Sell
50-day SMA: 12.86 Sell
200-day SMA: 11.87 Sell
8-day EMA: 11.94 Sell
20-day EMA: 12 Sell
50-day EMA: 12.64 Sell
200-day EMA: 12.22 Sell

WisdomTree EM ex-State-Owned Enterprises Earnings Growth & XSOE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

WisdomTree EM ex-State-Owned Enterprises Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):